2015-12-28 – Page 4 – China Stock Advice

UMC [UNITED MICROELECTRONICS] 6-K: www.umc.com Description 99.1 Announcement on 2015/12/01: To announce

[www.umc.com Description 99.1 Announcement on 2015/12/01: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2015/12/09: Represent subsidiary United Semiconductor (Xiamen) Co., Ltd.to announce related materials on acquisition of machinery and equipment 99.3 Announcement on 2015/12/11: Represent subsidiary HEJIAN (SUZHOU) TECHNOLOGY CO., LTD. to announce acquisition of UNITED SEMICONDUCTOR (XIAMEN) CO., LTD. 99.4 Announcement on 2015/12/16:] [FORM 6-K December 28, 2015 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu CFO Description 99 6K on 12/28/2015 6-K 1 htm_9933.htm LIVE FILING]

By info| 2016-03-16T00:09:22+00:00 December 28th, 2015|Categories: Chinese Stocks, UMC, Webplus ver|Tags: 0001033767, 2015-12-28, 3674, 6-K, SEMICONDUCTORS and RELATED DEVICES, UMC|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]

By info| 2016-03-28T18:47:59+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

GSI [GENERAL STEEL] 10-Q: Table of Contents Page Part I. FINANCIAL INFORMATION

[Table of Contents Page Part I. FINANCIAL INFORMATION Item 1. Unaudited Financial Statements. Condensed Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014. 3 Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2015 and 2014. 4 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Yunshan Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, John Chen, certify that: 1. I have reviewed this quarterly report on Form 10-Q of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 Yunshan Li Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 John Chen Chief Financial Officer]

By info| 2016-04-02T14:24:49+00:00 December 28th, 2015|Categories: Chinese Stocks, GSI, Webplus ver|Tags: 0001239188, 10-Q, 2015-12-28, 3310, GSI, STEEL WORKS, BLAST FURNACES and ROLLING and FINISHING MILLS|0 Comments

NCTY [The9] 6-K: THE9 LIMITED Jun Zhu Chairman and Chief Executive

[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Announces Unaudited Financial Information As of and For the Six Months Ended June 30, 2015 In compliance with NASDAQ Rule 5250(c)(2), The9 Limited (the Company) hereby announces its unaudited consolidated statement of income for the six months ended June 30, 2015 and its unaudited consolidated balance sheet as of]

By info| 2016-03-10T21:23:21+00:00 December 28th, 2015|Categories: Chinese Stocks, NCTY, Webplus ver|Tags: 0001296774, 2015-12-28, 6-K, 7389, NCTY, SERVICES-BUSINESS SERVICES, NEC|0 Comments

CCCR [China Commercial Credit] 8-K: (Original Filing)

[]

By info| 2016-03-16T17:13:31+00:00 December 28th, 2015|Categories: CCCR, Chinese Stocks, SEC Original|Tags: 0001556266, 2015-12-28, 6021, 8-K, CCCR, NATIONAL COMMERCIAL BANKS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: o Large accelerated filer

[o Large accelerated filer] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321093015.htm]

By info| 2016-03-28T18:49:11+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

XIN [Xinyuan Real Estate] 6-K: (Original Filing)

[Xinyuan Real Estate Co., Ltd. Announces Board Authorization to Repurchase Shares BEIJING, December 28, 2015 -- Xinyuan Real Estate Co., Ltd. (“Xinyuan” or “the Company”) (NYSE: XIN), an NYSE-listed real estate developer and property manager primarily in China and recently in other countries, today announced that effective December 28, 2015, the Board of Directors approved a $40 million share repurchase] []

By info| 2016-04-02T21:09:52+00:00 December 28th, 2015|Categories: Chinese Stocks, SEC Original, XIN|Tags: 0001398453, 1520, 2015-12-28, 6-K, GEN BUILDING CONTRACTORS - RESIDENTIAL BUILDINGS, XIN|0 Comments

TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding common shares: Number of shares held as of]

By info| 2016-03-12T13:00:04+00:00 December 28th, 2015|Categories: Chinese Stocks, SEC Original, TSM|Tags: 0001046179, 2015-12-28, 3674, 6-K, SEMICONDUCTORS and RELATED DEVICES, TSM|0 Comments

CCCR [China Commercial Credit] 8-K:

[]

By info| 2016-03-16T17:14:20+00:00 December 28th, 2015|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: 0001556266, 2015-12-28, 6021, 8-K, CCCR, NATIONAL COMMERCIAL BANKS|0 Comments

CPHI [CHINA PHARMA] 10-Q/A: (Original Filing)

[o Large accelerated filer o Accelerated filer o] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q/A of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 24, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qaex321063015.htm]

By info| 2016-03-28T18:50:31+00:00 December 28th, 2015|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q.A, 2015-12-28, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments